Aims and Scope of Annals of the Rheumatic Diseases
The Annals of the Rheumatic Diseases is a peer-reviewed medical journal. It is co-owned by the BMJ Group and the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes basic, clinical, and translational research and abstracts from conferences. The journal was established in 1939. It is available online by subscription and archived editions of the journal (older than one year) are available free of charge. Each issue, the editor-in-chief selects a paper to be published open access as an "Editors Choice". The editor-in-chief is Josef Smolen. Less
Key Metrics
CiteScore 

28.5
Eigenfactor 

0.05 - 0.1
H-Index 

272
Impact Factor 

>= 25
Scite Index 

0.88 5-Year SI

SJR 

Q1Immunology

SNIP 

5.22
Recommended pre-submission checks
Powered by 

Topics Covered on Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases Journal Specifications
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1935 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of the Rheumatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Annals of the Rheumatic Diseases
A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis.
- 23 Apr 2027
- Annals of the rheumatic diseases
EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 update.
- 25 Apr 2026
- Annals of the rheumatic diseases
Corrigendum to Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: A target trial emulation study Ann Rheum Dis 2025;84(11):1938-1947.
- 24 Apr 2026
- Annals of the rheumatic diseases
Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial.
- 22 Apr 2026
- Annals of the rheumatic diseases
The evolving landscape of complement therapeutics in rheumatology.
- 18 Apr 2026
- Annals of the rheumatic diseases
Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring system.
- 18 Apr 2026
- Annals of the rheumatic diseases
A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis.
- 23 Apr 2027
- Annals of the rheumatic diseases
EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 update.
- 25 Apr 2026
- Annals of the rheumatic diseases
Corrigendum to Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: A target trial emulation study Ann Rheum Dis 2025;84(11):1938-1947.
- 24 Apr 2026
- Annals of the rheumatic diseases
Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial.
- 22 Apr 2026
- Annals of the rheumatic diseases
The evolving landscape of complement therapeutics in rheumatology.
- 18 Apr 2026
- Annals of the rheumatic diseases
Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring system.
- 18 Apr 2026
- Annals of the rheumatic diseases